SIROGEN
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 May 2022)
What this means for you
This application is over — abandoned 16 May 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88106887
- Mark type
- Stylized text
- Filed
- 06 Sept 2018
- Published for opposition
- 12 Feb 2019
- Abandoned
- 16 May 2022
- Attorney of record
- Michael Bamberger
Goods and services
- Class 005 — Pharmaceuticals: An implantable drug delivery matrix for intraoperative delivery of sirolimus to the vascular wall, the formulation consisting of a collagen membrane incorporating an active pharmaceutical ingredient, namely, sirolimus, for improving functional outcomes of procedures that involve the creation of a vascular anastomosis administered by physicians during surgery
Owner
- Vascular Therapies, Inc., Cresskill, NJ, US
- Vascular Therapies, Inc., Cresskill, NJ, US
Prosecution history
- 16 May 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 May 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Sept 2021 — SOU EXTENSION 5 GRANTED
- 17 Sept 2021 — SOU EXTENSION 5 FILED
- 22 Sept 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Sept 2021 — SOU TEAS EXTENSION RECEIVED
- 08 Apr 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Apr 2021 — SOU EXTENSION 4 GRANTED
- 06 Apr 2021 — SOU EXTENSION 4 FILED
- 06 Apr 2021 — SOU TEAS EXTENSION RECEIVED
- 02 Oct 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Sept 2020 — SOU EXTENSION 3 GRANTED
- 30 Sept 2020 — SOU EXTENSION 3 FILED
- 30 Sept 2020 — SOU TEAS EXTENSION RECEIVED